Open AccessP719: EFFICACY AND SAFETY OF BOSUTINIB IN LATER‐LINE PATIENTS WITH CHRONIC MYELOID LEUKEMIA: A SUB‐ANALYSIS FROM THE PHASE 4 BYOND TRIAL
Author(s) -
GambacortiPasserini C.,
Brümmendorf T. H.,
Ernst T.,
Leip E.,
Purcell S.,
Viqueira A.,
Giles F. J.,
Rosti G.,
Hochhaus A.
Publication year - 2022
Publication title -
hemasphere
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.677
H-Index - 11
ISSN - 2572-9241
DOI - 10.1097/01.hs9.0000845760.12943.c0
Subject(s) - bosutinib , nilotinib , medicine , dasatinib , imatinib , myeloid leukemia , adverse effect , oncology